News & Perspective

Jun 01, 2015

Jun 01, 2015

News Scan for Jun 01, 2015

Ebola in Sierra Leone
DoD anthrax probe
Chikungunya cases
Avian flu in Taiwan

Feb 04, 2015

Feb 04, 2015
Ebola burial

Ebola uptick underscores response challenges

For the first time this year, all 3 nations see an increase in cases, while the CDC reports on a December lab incident.

Aug 27, 2014

Aug 27, 2014

News Scan for Aug 27, 2014

Pause for US labs
Ebola guidance for first responders
USAID Ebola funding
Chikungunya in US
Dengue in Japan

May 02, 2014

May 02, 2014

News Scan for May 02, 2014

More MERS-CoV antibodies
Ebola in Guinea
Renamed biodefense board
Universal flu vaccine

May 02, 2013

May 02, 2013

Study: Lab-made H5N1-H1N1 viruses spread in guinea pigs

(CIDRAP News) – Chinese scientists report that lab-generated hybrid viruses combining genes from avian H5N1 and pandemic 2009 H1N1 (pH1N1) influenza viruses can achieve airborne spread between guinea pigs, a finding that seems likely to renew the debate about the risks of creating novel viruses that might be able to spark a human pandemic.

Nov 15, 2007

Nov 15, 2007

THE PANDEMIC VACCINE PUZZLE Can we vaccinate enough people in time to matter?

Maryn McKennaContributing Writer

(CIDRAP News) – This in-depth article investigates the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. Its seven parts put advances in vaccine technology in perspective by illuminating the formidable barriers to producing an effective and widely usable vaccine in a short time frame.

Oct 29, 2007

Oct 29, 2007

THE PANDEMIC VACCINE PUZZLE Part 3: H5N1 poses major immunologic challenges

Editor's note: This is the third in a seven-part series investigating the prospects for development of vaccines to head off the threat of an influenza pandemic posed by the H5N1 avian influenza virus. The series puts promising advances in vaccine technology in perspective by illuminating the formidable barriers to producing large amounts of an effective and widely usable vaccine in a short time frame.

Sort Results

 

Narrow results

by organization

Newsletter Sign-up

Get CIDRAP news and other free newsletters.

Sign up now»

OUR UNDERWRITERS

Unrestricted financial support provided by

Bentson Foundation 3M Gilead 
Grant support for ASP provided by

  Become an underwriter»